Cluster headaches (CH) are a severe form of primary headache disorder characterized by recurrent, unilateral, excruciating pain attacks associated with autonomic symptoms. Despite being relatively rare, CH significantly impacts the quality of life of affected individuals. This review provides an overview of the pathophysiology, clinical manifestations, diagnostic criteria, and management strategies for cluster headaches based on current evidence and clinical practice.

Introduction: Cluster headaches are one of the most painful types of primary headache disorders, often referred to as “suicide headaches” due to the intensity of pain experienced by patients. Understanding the underlying mechanisms driving cluster headaches is crucial for accurate diagnosis and effective management.

Epidemiology: Cluster headaches are relatively rare, affecting approximately 0.1% of the population. They typically manifest in adults, with a male-to-female predominance ratio of approximately 2:1. The peak age of onset is between 20 to 40 years, although they can occur at any age.

Pathophysiology: The pathophysiology of cluster headaches involves complex interplay between neurovascular and neurogenic mechanisms. Activation of the trigeminal-autonomic reflex leads to vasodilation of cranial blood vessels, accompanied by release of neuropeptides such as calcitonin gene-related peptide (CGRP) and substance P. Central sensitization and dysfunction of the hypothalamus are also implicated in the pathogenesis of cluster headaches, contributing to the circadian and seasonal patterns observed in attacks.

Clinical Features: Cluster headaches are characterized by severe, unilateral pain typically localized around the orbit, temple, or periorbital region. The pain is described as stabbing, burning, or piercing in nature and reaches peak intensity within minutes, often waking patients from sleep. Accompanying autonomic symptoms include ipsilateral lacrimation, conjunctival injection, nasal congestion, rhinorrhea, and ptosis. Attacks occur in clusters, with multiple episodes per day lasting from 15 minutes to 3 hours, followed by periods of remission lasting weeks to months.

Diagnosis: The diagnosis of cluster headaches is primarily based on clinical history and examination. The International Classification of Headache Disorders (ICHD) criteria provides guidelines for diagnosing CH. Neuroimaging may be indicated to rule out secondary causes of headache, particularly in atypical presentations or new-onset symptoms.

Management: The management of cluster headaches involves acute treatment aimed at aborting individual attacks and preventive strategies to reduce the frequency and severity of episodes. Acute treatment options include oxygen therapy, triptans, and intranasal lidocaine. Preventive therapies include verapamil, corticosteroids, lithium, and antiepileptic drugs such as topiramate and valproate. In refractory cases, neuromodulation techniques such as occipital nerve stimulation and deep brain stimulation may be considered.

Conclusion: Cluster headaches represent a debilitating condition characterized by severe pain and autonomic symptoms, significantly impacting the quality of life of affected individuals. A multidisciplinary approach involving neurologists, pain specialists, and headache nurses is essential for comprehensive management. Further research is warranted to elucidate the underlying mechanisms of cluster headaches and optimize therapeutic interventions to improve patient outcomes.